{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T15:40:03Z","timestamp":1748101203246,"version":"3.41.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NCI","award":["T32 CA116339","T32 CA116339"],"award-info":[{"award-number":["T32 CA116339","T32 CA116339"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["MRSG-13-157-01-CPPB","MRSG-13-157-01-CPPB"],"award-info":[{"award-number":["MRSG-13-157-01-CPPB","MRSG-13-157-01-CPPB"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10552-025-01971-y","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T19:47:52Z","timestamp":1740080872000},"page":"725-732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementing motivational interviewing to improve endocrine therapy adherence among breast cancer patients: a qualitative process evaluation of the getset pilot intervention"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5406","authenticated-orcid":false,"given":"Victoria J.","family":"Dunsmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Drier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin R.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niasha","family":"Fray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Reeder-Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"24","key":"1971_CR1","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","volume":"16","author":"KM O'Brien","year":"2010","unstructured":"O\u2019Brien KM, Cole SR, Tse CK et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16(24):6100\u20136110","journal-title":"Clin Cancer Res"},{"key":"1971_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10549-014-2957-z","volume":"145","author":"KE Reeder-Hayes","year":"2014","unstructured":"Reeder-Hayes KE, Meyer AM, Dusetzina B, Liu H,  Wheeler SB (2014) Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat 145:743\u2013751","journal-title":"Breast Cancer Res Treat"},{"key":"1971_CR3","doi-asserted-by":"publisher","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687\u20131717. https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0","DOI":"10.1016\/S0140-6736(05)66544-0"},{"issue":"11","key":"1971_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/sj.bjc.6604758","volume":"99","author":"C McCowan","year":"2008","unstructured":"McCowan C, Shearer J, Donnan PT et al (2008) Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 99(11):1763\u20131768","journal-title":"Br J Cancer"},{"issue":"27","key":"1971_CR5","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","volume":"28","author":"DL Hershman","year":"2010","unstructured":"Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120\u20134128","journal-title":"J Clin Oncol"},{"issue":"18","key":"1971_CR6","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1200\/JCO.2010.33.3179","volume":"29","author":"AI Neugut","year":"2011","unstructured":"Neugut AI, Subar M, Wilde ET et al (2011) Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29(18):2534\u20132542","journal-title":"J Clin Oncol"},{"issue":"2","key":"1971_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529\u2013537","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1971_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.critrevonc.2009.02.001","volume":"73","author":"P Hadji","year":"2010","unstructured":"Hadji P (2010) Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy. Crit Rev Oncol Hematol 73(2):156\u2013166","journal-title":"Crit Rev Oncol Hematol"},{"key":"1971_CR9","doi-asserted-by":"publisher","unstructured":"Bhatta SS, Hou N, Moton ZN, et al (2013) Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer.\u00a0Springerplus. 2013;2:356. https:\/\/doi.org\/10.1186\/2193-1801-2-356","DOI":"10.1186\/2193-1801-2-356"},{"issue":"3","key":"1971_CR10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s13187-018-1347-3","volume":"34","author":"AL Sutton","year":"2019","unstructured":"Sutton AL, He J, Edmonds MC, Sheppard VB (2019) Medical mistrust in black breast cancer patients: acknowledging the roles of the trustor and the trustee. J Cancer Educ 34(3):600\u2013607. https:\/\/doi.org\/10.1007\/s13187-018-1347-3","journal-title":"J Cancer Educ"},{"key":"1971_CR11","doi-asserted-by":"publisher","unstructured":"Anderson JN, Graff JC, Krukowski RA et al (2021) Nobody Will Tell You. You've Got to Ask!\": An Examination of Patient-Provider Communication Needs and Preferences among Black and White Women with Early-Stage Breast Cancer.\u00a0Health Commun 36(11):1331\u20131342. https:\/\/doi.org\/10.1080\/10410236.2020.1751383","DOI":"10.1080\/10410236.2020.1751383"},{"issue":"3","key":"1971_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1055-9965.EPI-12-1225","volume":"22","author":"JC Livaudais","year":"2013","unstructured":"Livaudais JC, Lacroix A, Chlebowski RT et al (2013) Racial\/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women\u2019s health initiative. Cancer Epidemiol Biomarkers Prev 22(3):365\u2013373. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1225","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1971_CR13","doi-asserted-by":"crossref","unstructured":"Gamble VN (2016) Under the shadow of Tuskegee: African Americans and health care.\u00a0Health Psychol, pp 434\u2013441.","DOI":"10.4324\/9781315664033-47"},{"issue":"6","key":"1971_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pon.750","volume":"13","author":"KT Ashing-Giwa","year":"2004","unstructured":"Ashing-Giwa KT, Padilla G, Tejero J et al (2004) Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology 13(6):408\u2013428","journal-title":"Psychooncology"},{"issue":"S3","key":"1971_CR15","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2105\/AJPH.2014.302490","volume":"105","author":"MC Roberts","year":"2015","unstructured":"Roberts MC, Wheeler SB, Reeder-Hayes K (2015) Racial\/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review. Am J Public Health 105(S3):e4\u2013e15","journal-title":"Am J Public Health"},{"issue":"2","key":"1971_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10549-006-9193-0","volume":"99","author":"TL Lash","year":"2006","unstructured":"Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA (2006) Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 99(2):215\u2013220","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1971_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/cancers15071973","volume":"15","author":"SB Wheeler","year":"2023","unstructured":"Wheeler SB, Spencer J, Drier SW, Fray N, Reeder-Hayes KE (2023) Motivational interviewing counseling to increase endocrine therapy adherence in diverse patients. Cancers 15(7):1973","journal-title":"Cancers"},{"key":"1971_CR18","doi-asserted-by":"crossref","unstructured":"Emmons KM, Rollnick S (2001) Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med 20(1):68\u201374.","DOI":"10.1016\/S0749-3797(00)00254-3"},{"key":"1971_CR19","volume-title":"Motivational interviewing: preparing people for change","author":"WR Miller","year":"2002","unstructured":"Miller WR, Rollnick S (2002) Motivational interviewing: preparing people for change, 2nd edn. Guilford Press, New York","edition":"2"},{"key":"1971_CR20","volume-title":"Motivational interviewing in health care: helping patients change behavior","author":"S Rollnick","year":"2008","unstructured":"Rollnick S, Miller WR, Butler C (2008) Motivational interviewing in health care: helping patients change behavior. Guilford Press, New York"},{"issue":"513","key":"1971_CR21","first-page":"305","volume":"55","author":"S Rubak","year":"2005","unstructured":"Rubak S, Sandbaek A, Lauritzen T, Christensen B (2005) Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 55(513):305\u2013312","journal-title":"Br J Gen Pract"},{"issue":"9","key":"1971_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1467-789X.2011.00892.x","volume":"12","author":"MJ Armstrong","year":"2011","unstructured":"Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR (2011) Motivational interviewing to improve weight loss in overweight and\/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 12(9):709\u2013723","journal-title":"Obes Rev"},{"issue":"9\u201310","key":"1971_CR23","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1365-2702.2010.03558.x","volume":"20","author":"DR Thompson","year":"2011","unstructured":"Thompson DR, Chair SY, Chan SW, Astin F, Davidson PM, Ski CF (2011) Motivational interviewing: a useful approach to improving cardiovascular health? J Clin Nurs 20(9\u201310):1236\u20131244","journal-title":"J Clin Nurs"},{"issue":"5","key":"1971_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1037\/0022-006X.71.5.843","volume":"71","author":"BL Burke","year":"2003","unstructured":"Burke BL, Arkowitz H, Menchola M (2003) The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 71(5):843\u2013861","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"1971_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC (2009) Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 4(1):1\u201315","journal-title":"Implement Sci"},{"issue":"1","key":"1971_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J (2022) The updated consolidated framework for implementation research based on user feedback. Implement Sci 17(1):1\u201316","journal-title":"Implement Sci"},{"issue":"1","key":"1971_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-016-0437-z","volume":"11","author":"MA Kirk","year":"2015","unstructured":"Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L (2015) A systematic review of the use of the consolidated framework for implementation research. Implement Sci 11(1):1\u201313","journal-title":"Implement Sci"},{"issue":"4","key":"1971_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1089\/jayao.2015.0028","volume":"4","author":"YP Wu","year":"2015","unstructured":"Wu YP, Yi J, McClellan J et al (2015) Barriers and facilitators of healthy diet and exercise among adolescent and young adult cancer survivors: implications for behavioral interventions. J Adolesc Young Adult Oncol 4(4):184\u2013191. https:\/\/doi.org\/10.1089\/jayao.2015.0028","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"7","key":"1971_CR29","doi-asserted-by":"publisher","first-page":"e0286630","DOI":"10.1371\/journal.pone.0286630","volume":"18","author":"B Muluneh","year":"2023","unstructured":"Muluneh B, Muir MA, Collins JB, Proco D, Mackler E, Leak Bryant A et al (2023) Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings. Plos One 18(7):e0286630","journal-title":"Plos One"},{"issue":"6","key":"1971_CR30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/tbm\/ibaa118","volume":"10","author":"P Konstantinou","year":"2020","unstructured":"Konstantinou P, Kassianos AP, Georgiou G et al (2020) Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Transl Behav Med 10(6):1390\u20131398. https:\/\/doi.org\/10.1093\/tbm\/ibaa118","journal-title":"Transl Behav Med"},{"key":"1971_CR31","unstructured":"Motivational Interviewing - Foundational. Psychwire.com. Accessed April 1, 2024. https:\/\/psychwire.com\/motivational-interviewing\/mi-foundational"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01971-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-01971-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01971-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T15:02:44Z","timestamp":1748098964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-01971-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1971"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-01971-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SBW and KRH receive unrelated grant funding paid to her institution from Pfizer and Astra Zeneca.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"University of North Carolina Institutional Review Board (IRB# 13-0736).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}